As the cost and risk involved in developing new pharmaceuticals continue to increase and tougher regulatory requirements are put in place, the need for technologies that accelerate the process of drug discovery becomes more urgent. In this article, we describe four instances of the use of Attana biosensors to obtain data that increases our understanding of molecular interactions and enhances our ability to select drug candidates based on physiologically relevant information. A TECAN Whitepaper